| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Gary D. Rubin | Director, 10%+ Owner | $4,586,464 | 01 Jul 2024 | ||
| STEVEN GIRGENTI | Executive Chairman, Director | $2,846,638 | 10 Jan 2025 | ||
| Roby Joyce | Director | $1,721,825 | 01 Jul 2024 | ||
| Nathan Perlmutter | 10%+ Owner | $1,377,218 | 06 Sep 2022 | ||
| Maria Zannes | President & CEO, Director | $644,803 | 10 Jan 2025 | ||
| Mohsin Y. Meghji | Director | $454,219 | 01 Oct 2023 | ||
| Robert A. Anderson | Director | $434,430 | 01 Jul 2024 | ||
| PETER S. KNIGHT | Director | $311,256 | 01 Jul 2024 | ||
| James Michael Edwards | VP and CFO | $301,983 | 10 Jan 2025 | ||
| STUART DIAMOND | Director | $262,583 | 01 Jul 2024 | ||
| Jamie Platt | Director | $145,082 | 01 Jul 2024 | ||
| Michael Dougherty | Chief Financial Officer | $124,620 | 31 Jan 2024 | ||
| Timothy P. Zannes | Secretary, EVP, Gen. Counsel | $119,000 | 10 Jan 2025 | ||
| Vivienne Rebel | Chief Sci. & Med. Officer, EVP | $68,417 | 31 Jan 2024 | ||
| Xavier T. Reveles | Chief Operating Officer | $30,102 | 10 Jan 2025 | ||
| Roberto Rios | Director | $208 | 12 Aug 2025 | ||
| John J. Oppenheimer | Director | 12 Aug 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|